Letter: Breast cancer regression under oestrogen therapy.
作者信息
L'Hermite M, Robyn C, Heuson J C, Rozencweig M
出版信息
Br Med J. 1974 Mar 2;1(5904):390. doi: 10.1136/bmj.1.5904.390.
Abstract
摘要
相似文献
1
Letter: Breast cancer regression under oestrogen therapy.信件：雌激素治疗下的乳腺癌消退
Br Med J. 1974 Mar 2;1(5904):390. doi: 10.1136/bmj.1.5904.390.
2
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.萘福昔定与炔雌醇治疗晚期乳腺癌的对比试验：一项欧洲癌症研究与治疗组织（E.O.R.T.C.）的研究
Br Med J. 1975 Jun 28;2(5973):711-3. doi: 10.1136/bmj.2.5973.711.
3
[Prolactin: radioimmunologic levels and changes under ethinyl estradiol and nafoxidine in advanced breast cancers in women].[催乳素：女性晚期乳腺癌患者在乙炔雌二醇和萘福昔定作用下的放射免疫水平及变化]
Ann Endocrinol (Paris). 1973 Sep-Oct;34(5):601-2.
4
Antiestrogens in treatment of breast cancer.抗雌激素药物在乳腺癌治疗中的应用
Cancer. 1977 Jun;39(6 Suppl):2959-64. doi: 10.1002/1097-0142(197706)39:6<2959::aid-cncr2820390682>3.0.co;2-2.
5
Human breast cancer and estrogen receptor.人类乳腺癌与雌激素受体
Arch Chir Neerl. 1973;25(4):393-7.
6
Therapy with nafoxidine for patients suffering from postmenopausal ulcerated mammary cancer.诺氟沙星对绝经后溃疡性乳腺癌患者的治疗。
Panminerva Med. 1976 Mar-Apr;18(3-4):137-41.
7
[Additive treatment of metastasizing breast cancer with special reference to postmenopausal age (results of a randomized study)].[转移性乳腺癌的附加治疗，特别涉及绝经后年龄（一项随机研究的结果）]
Strahlentherapie. 1976 Sep;152(3):235-47.
8
[On the value of a combination of estrogens and alkylating substances in the treatment of a metastasizing breast carcinoma of the female].[雌激素与烷化剂联合应用治疗女性转移性乳腺癌的价值]
Dtsch Med Wochenschr. 1966 Oct 7;91(40):1775-9. doi: 10.1055/s-0028-1111590.
9
Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.左旋多巴与萘福昔定治疗晚期乳腺癌的对照临床试验：一项欧洲癌症研究与治疗组织（E.O.R.T.C.）的研究
Br Med J. 1975 Jun 28;2(5973):714-5. doi: 10.1136/bmj.2.5973.714.
10
Premarin in the management of metastatic breast carcinoma in post-menopausal patients.倍美力用于绝经后患者转移性乳腺癌的治疗
Clin Oncol. 1979 Jun;5(2):159-62.
本文引用的文献
1
Massive estrogen administration in premenopausal women with metastatic breast cancer.对患有转移性乳腺癌的绝经前女性大量施用雌激素。
Cancer. 1962 May-Jun;15:641-8. doi: 10.1002/1097-0142(196205/06)15:3<641::aid-cncr2820150330>3.0.co;2-9.
2
Hormonal therapy in cancer of the breast. VII. Effect of conjugated estrogens (equine) on clinical course and hormonal excretion.乳腺癌的激素治疗。VII. 结合雌激素（马）对临床病程和激素排泄的影响。
Cancer. 1954 Jul;7(4):758-63. doi: 10.1002/1097-0142(195407)7:4<758::aid-cncr2820070415>3.0.co;2-l.
3
Pituitary function and hormonal therapy of experimental breast cancer.
Cancer Res. 1965 Aug;25(7):1146-61.
4
Anti-oestrogens and breast cancer.抗雌激素与乳腺癌
Eur J Cancer (1965). 1971 Feb;7(1):57-64. doi: 10.1016/0014-2964(71)90095-8.
5
Two modes of interaction between oestrogen and anti-oestrogen.雌激素与抗雌激素之间的两种相互作用模式。
Acta Endocrinol (Copenh). 1970 May;64(1):47-58. doi: 10.1530/acta.0.0640047.
6
Prolactin-dependent rat mammary cancer: a model for man?催乳素依赖性大鼠乳腺癌：人类的一种模型？
Trans Assoc Am Physicians. 1969;82:225-38.
7
Circadian periodicity of serum prolactin concentration in man.男性血清催乳素浓度的昼夜节律性。
Br Med J. 1972 Sep 2;3(5826):561-2. doi: 10.1136/bmj.3.5826.561.
8
Relation of prolactin and estrogen to mammary tumorigenesis in the rat.催乳素和雌激素与大鼠乳腺肿瘤发生的关系。
J Natl Cancer Inst. 1972 Apr;48(4):1217-24.
9
Hypothesis: breast cancer regression under oestrogen therapy.假设：雌激素治疗下的乳腺癌消退。
Br Med J. 1973 Aug 25;3(5877):446-50. doi: 10.1136/bmj.3.5877.446.
10
Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.人乳腺癌组织中的雌激素受体及对内分泌治疗的反应
Br Med J. 1973 Jun 30;2(5869):750-2. doi: 10.1136/bmj.2.5869.750.
Zotero 插件